BJDXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Bluejay Diagnostics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.70−0.05 (-6.46%)
Close on Oct 19, 2026
- Market cap
- $1.45M
- P/E (TTM)
- –
- Dividend yield
- –
Bluejay Diagnostics statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Bluejay Diagnostics | Industry median |
|---|---|---|
| Market Cap | $3.11M | $229.23M |
| Enterprise Value | -$6.49M | $194.73M |
| PB Ratio | 0.33 | 3.19 |
| P/TBV Ratio | 0.33 | 4.69 |
Income (trailing twelve months)
| Measure | Bluejay Diagnostics | Industry median |
|---|---|---|
| Operating Income | -$7.37M | -$4.31M |
| Net Income | -$7.27M | -$6.57M |
| EBITDA | -$7.37M | -$1.98M |
Returns
| Measure | Bluejay Diagnostics | Industry median |
|---|---|---|
| Return on Equity (ROE) | -98.9% | -19.2% |
| Return on Assets (ROA) | -81.1% | -13.3% |
| Return on Invested Capital (ROIC) | -1755.3% | -4.11% |
| Return on Capital Employed (ROCE) | -78.2% | -9.07% |
Balance sheet
| Measure | Bluejay Diagnostics | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $9.60M | $37.33M |
| Net Cash (Debt) | $9.60M | $3.92M |
| Net Cash Per Share | $2.15 | $0.28 |
| Equity (Book Value) | $9.41M | $57.36M |
| Book Value Per Share | $2.11 | $2.81 |
| Tangible Book Value | $9.41M | $10.71M |
| Working Capital | $7.70M | $54.64M |
Financial position
| Measure | Bluejay Diagnostics | Industry median |
|---|---|---|
| Current Ratio | 4.64 | 2.50 |
| Quick Ratio | 4.53 | 1.54 |
Cash flow (trailing twelve months)
| Measure | Bluejay Diagnostics | Industry median |
|---|---|---|
| Operating Cash Flow | -$5.90M | -$653.46K |
Efficiency
| Measure | Bluejay Diagnostics | Industry median |
|---|---|---|
| Profits Per Employee | -$1.21M | -$52.11K |
| Employee Count | 6 | 197 |
Dividends and yields
| Measure | Bluejay Diagnostics | Industry median |
|---|---|---|
| Earnings Yield | -233.7% | -6.92% |
| Buyback Yield | -421.8% | 0.78% |
| Shareholder Yield | -421.8% | 0.84% |
Shares
| Measure | Bluejay Diagnostics | Industry median |
|---|---|---|
| Shares Outstanding | 4,468,050 | 44,856,700 |
| Shares Change (QoQ) | 91.7% | 0.27% |
| Float | 3,176,320 | 36,934,400 |
| Shares Held by Insiders | 28.9% | 10.6% |
| Shares Held by Institutions | 4.84% | 63.5% |
Scores
| Measure | Bluejay Diagnostics | Industry median |
|---|---|---|
| Altman Z-Score | -5.98 | 1.95 |
| Piotroski F-Score | 3 | 5 |
Calculated by StockData from Bluejay Diagnostics's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.